Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Aug 25, 2022
Date Accepted: Mar 15, 2023

The final, peer-reviewed published version of this preprint can be found here:

The Efficacy and Safety of Telerehabilitation for Fibromyalgia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Wu YQ, Long Y, Peng WJ, Gong C, Liu YQ, Peng XM, Zhong YB, Luo Y, Wang MY

The Efficacy and Safety of Telerehabilitation for Fibromyalgia: Systematic Review and Meta-analysis of Randomized Controlled Trials

J Med Internet Res 2023;25:e42090

DOI: 10.2196/42090

PMID: 37097721

PMCID: 10170363

Efficacy and Safety of Telerehabilitation for Fibromyalgia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • Yong-Qiang Wu; 
  • Yi Long; 
  • Wei-Jie Peng; 
  • Cheng Gong; 
  • Yue-Quan Liu; 
  • Xu-Miao Peng; 
  • Yan-Biao Zhong; 
  • Yun Luo; 
  • Mao-Yuan Wang

ABSTRACT

Background:

Fibromyalgia (FM) is a chronic pain syndrome characterized by persistent and widespread musculoskeletal pain. Telerehabilitation is a promising treatment for patients with FM through long-term monitoring, intervention, supervision, consultation, and education.

Objective:

To evaluate the efficacy and safety of telerehabilitation services in patients with FM.

Methods:

Randomized controlled trials (RCTs) related to FM and telerehabilitation were systematically searched in the PubMed, Cochrane Library, ScienceDirect, Ovid MEDLINE, Embase, and Web of Science databases from inception to May 25, 2022. Efficacy outcomes were evaluated using the Fibromyalgia Impact Questionnaire (FIQ) scale, pian intensity, depression, pain catastrophizing, and quality of life (QoL). The safety outcomes were evaluated based on adverse events. RevMan software 5.4 was used for the data analysis.

Results:

Thirteen RCTs with 872 subjects were included in this meta-analysis. The pooled results indicated that the telerehabilitation improved the FIQ score (mean difference [MD]: -7.78; 95% confidence interval [CI]: -11.64, -3.93; p < 0.001;), pain intensity (standardized mean difference [SMD]: -0.59; 95% CI -0.78, -0.40; p < 0.001), depression levels (SMD: -0.43; 95% CI -0.67, -0.19; p < 0.001, pain catastrophizing (MD: -6.29; 95% CI -10.06, -2.53; p = 0.001), and QoL (SMD: 0.27; 95% CI 0.08, 0.46; p =0.005). Only one RCT reported a mild adverse event of telerehabilitation; the other twelve RCTs did not mention this.

Conclusions:

Telerehabilitation can improve FM symptoms and QoL. However, the safety of telerehabilitation remains uncertain for the management of FM.


 Citation

Please cite as:

Wu YQ, Long Y, Peng WJ, Gong C, Liu YQ, Peng XM, Zhong YB, Luo Y, Wang MY

The Efficacy and Safety of Telerehabilitation for Fibromyalgia: Systematic Review and Meta-analysis of Randomized Controlled Trials

J Med Internet Res 2023;25:e42090

DOI: 10.2196/42090

PMID: 37097721

PMCID: 10170363

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.